Medtronic (MDT) Cost of Revenue (2014 - 2026)

Medtronic's Cost of Revenue history runs 13 years deep, the most recent figure standing at $3.3 billion for Q1 2026.

• In Q1 2026, Cost of Revenue rose 17.34% year-over-year to $3.3 billion; the TTM figure through Jan 2026 stood at $12.5 billion (up 8.15% YoY), while the FY2025 annual figure was $11.6 billion, up 3.71% from the prior year.
• Cost of Revenue came in at $3.3 billion for Q1 2026 at Medtronic, up from $3.1 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $3.3 billion in Q1 2026 to a low of $2.5 billion in Q1 2022.
• A 5-year average of $2.8 billion and a median of $2.8 billion in 2025 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue declined 6.18% in 2022 and grew 17.34% in 2026, its largest moves.
• Medtronic's Cost of Revenue stood at $2.5 billion in 2022, then gained by 8.92% to $2.8 billion in 2023, then grew by 6.7% to $2.9 billion in 2024, then advanced by 3.9% to $3.1 billion in 2025, then rose by 6.53% to $3.3 billion in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $3.3 billion, $3.1 billion, and $3.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison